Literature DB >> 27653005

Clinical Effect of Sex-Specific Cutoff Values of High-Sensitivity Cardiac Troponin T in Suspected Myocardial Infarction.

Maria Rubini Giménez1, Raphael Twerenbold2, Jasper Boeddinghaus2, Thomas Nestelberger2, Christian Puelacher2, Petra Hillinger3, Karin Wildi2, Cedric Jaeger2, Karin Grimm2, Karl-Frieder Heitzelmann3, Zaid Sabti3, Patrick Badertscher3, Janosch Cupa3, Ursina Honegger3, Nicolas Schaerli3, Nikola Kozhuharov3, Jeanne du Fay de Lavallaz3, Beatriz Lopez4, Emilio Salgado4, Òscar Miró4, F Javier Martín-Sánchez5, Esther Rodríguez Adrada5, Beata Morawiec6, Jiri Parenica7, Eva Ganovska7, Claire Neugebauer3, Katharina Rentsch8, Jens Lohrmann3, Stefan Osswald3, Tobias Reichlin2, Christian Mueller2.   

Abstract

Importance: It is currently unknown whether the uniform (universal clinical practice for more than 2 decades) or 2 sex-specific cutoff levels are preferable when using high-sensitivity cardiac troponin T (hs-cTnT) levels in the diagnosis of acute myocardial infarction (AMI). Objective: To improve the management of suspected AMI in women by exploring sex-specific vs uniform cutoff levels for hs-cTnT. Design, Setting, and Participants: In an ongoing prospective, diagnostic, multicenter study conducted at 9 emergency departments, the present study evaluated patients enrolled from April 21, 2006, through June 5, 2013. The participants included 2734 adults presenting with suspected AMI. Duration of follow-up was 2 years, and data analysis occurred from June 5 to December 21, 2015. Interventions: The final diagnosis was centrally adjudicated by 2 independent cardiologists using all available information, including measurements of serial hs-cTnT blood concentrations twice: once using the uniform 99th percentile cutoff value level of 14 ng/L and once using sex-specific 99th percentile levels of hs-cTnT (women, 9 ng/L; men, 15.5 ng/L). Main Outcomes and Measures: Diagnostic reclassification in women and men using sex-specific vs the uniform cutoff level in the diagnosis of AMI.
Results: Of the 2734 participants, 876 women (32%) and 1858 men (68%) were included. Median (interquartile range) age was 68 (55-77) and 59 (48-71) years, respectively. With the use of the uniform cutoff value, 127 women (14.5%) and 345 men (18.6%) received a final diagnosis of AMI. Among these, at emergency department presentation, levels of hs-cTnT were already above the uniform cutoff value in 427 patients (sensitivity, 91.3% [95% CI, 85%-95.6%] in women vs 90.7% [95% CI, 87.1%-93.5% in men]; specificity, 79.2% [95% CI, 76.1%-82.1%] in women vs 78.5% [95% CI, 76.4%-80.6%] in men). After readjudication using sex-specific 99th percentile levels, diagnostic reclassification regarding AMI occurred in only 3 patients: 0.11% (95% CI, 0.02-0.32) of all patients and 0.6% (95% CI, 0.13-1.85) of patients with AMI. The diagnosis in 2 women was upgraded from unstable angina to AMI, and the diagnosis in 1 man was downgraded from AMI to unstable angina. These diagnostic results were confirmed when using 2 alternative pairs of uniform and sex-specific cutoff values. Conclusions and Relevance: The uniform 99th percentile should remain the standard of care when using hs-cTnT levels for the diagnosis of AMI.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27653005     DOI: 10.1001/jamacardio.2016.2882

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  18 in total

Review 1.  High-sensitivity assays for troponin in patients with cardiac disease.

Authors:  Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg
Journal:  Nat Rev Cardiol       Date:  2017-04-06       Impact factor: 32.419

Review 2.  Assessing and Modifying Coronary Artery Disease Risk in Women.

Authors:  Amy Sarma; Nandita S Scott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

3.  Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay.

Authors:  Bryn E Mumma; Scott D Casey; Robert K Dang; Michelle K Polen; Jasmanpreet C Kaur; John Rodrigo; Daniel J Tancredi; Robert A Narverud; Ezra A Amsterdam; Nam Tran
Journal:  Ann Emerg Med       Date:  2020-08-15       Impact factor: 5.721

Review 4.  Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives.

Authors:  Daniel E Forman; James A de Lemos; Leslee J Shaw; David B Reuben; Radmila Lyubarova; Eric D Peterson; John A Spertus; Susan Zieman; Marcel E Salive; Michael W Rich
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

Review 5.  Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy.

Authors:  Nicholas Wettersten; Yu Horiuchi; Alan Maisel
Journal:  Fac Rev       Date:  2021-03-31

6.  Associations between cardiac troponin, mortality and subsequent use of cardiovascular services: differences in sex and ethnicity.

Authors:  David E Winchester; Kristopher Kline; Christopher Estel; Dhruv Mahtta; Sean Taasan; Franck W Peacock
Journal:  Open Heart       Date:  2018-01-30

Review 7.  Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.

Authors:  Pankaj Garg; Paul Morris; Asma Lina Fazlanie; Sethumadhavan Vijayan; Balazs Dancso; Amardeep Ghosh Dastidar; Sven Plein; Christian Mueller; Philip Haaf
Journal:  Intern Emerg Med       Date:  2017-02-11       Impact factor: 3.397

Review 8.  Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women.

Authors:  Anoop S V Shah; Amy V Ferry; Nicholas L Mills
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

9.  Age-sex distribution of patients with high-sensitivity troponin T levels below the 99th percentile.

Authors:  Jie-Yin Liu; Qiao-Wei Jia; Xiao-Ling Zang; Rong-Hu Wang; Chun-Jian Li; Lian-Sheng Wang; Wen-Zhu Ma; Zhi-Jian Yang; En-Zhi Jia
Journal:  Oncotarget       Date:  2017-08-18

10.  High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study.

Authors:  Tar-Choon Aw; Wei-Ting Huang; Thu-Thao Le; Chee-Jian Pua; Briana Ang; Soon-Kieng Phua; Khung-Keong Yeo; Stuart A Cook; Calvin W L Chin
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.